Total Payments
$4,918
2024 Payments
$1,006
Companies
32
Transactions
172
Medicare Patients
2,136
Medicare Billing
$316,978
Payment Breakdown by Category
Food & Beverage$4,769 (97.0%)
Education$148.79 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,769 | 168 | 97.0% |
| Education | $148.79 | 4 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $913.88 | 41 | $0 (2024) |
| Amgen Inc. | $671.81 | 14 | $0 (2024) |
| Lilly USA, LLC | $369.99 | 15 | $0 (2024) |
| Medtronic, Inc. | $292.91 | 4 | $0 (2023) |
| Abbott Laboratories | $246.14 | 10 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $230.72 | 13 | $0 (2020) |
| Corcept Therapeutics | $220.78 | 6 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $212.64 | 11 | $0 (2024) |
| Medtronic MiniMed, Inc. | $209.32 | 2 | $0 (2019) |
| Ascendis Pharma Inc | $203.47 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,006 | 32 | Amgen Inc. ($268.35) |
| 2023 | $1,095 | 30 | Medtronic, Inc. ($292.91) |
| 2022 | $726.18 | 31 | Novo Nordisk Inc ($179.64) |
| 2020 | $162.87 | 10 | Novo Nordisk Inc ($92.59) |
| 2019 | $343.17 | 10 | Medtronic MiniMed, Inc. ($96.61) |
| 2018 | $614.52 | 11 | Novo Nordisk Inc ($226.23) |
| 2017 | $970.19 | 48 | Novo Nordisk Inc ($225.17) |
All Payment Transactions
172 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Ascendis Pharma Inc | Yorvipath (Drug) | Food and Beverage | In-kind items and services | $78.48 | General |
| Category: Endocrinology | ||||||
| 11/26/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $22.69 | General |
| 11/07/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: DIABETES MEDICINE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $45.94 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $104.60 | General |
| Category: Automated insulin delivery system | ||||||
| 08/28/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $31.35 | General |
| Category: Nephrology | ||||||
| 07/30/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Bone Health | ||||||
| 06/26/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 05/28/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.62 | General |
| 05/14/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Bone Health | ||||||
| 04/30/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: Endocrinology | ||||||
| 04/30/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: Endocrinology | ||||||
| 04/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Cardio-renal | ||||||
| 03/21/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 03/20/2024 | Amgen Inc. | Parsabiv (Drug), TAVNEOS | Food and Beverage | In-kind items and services | $32.29 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 457 | 679 | $216,016 | $53,517 |
| 2022 | 9 | 481 | 2,412 | $233,778 | $77,273 |
| 2021 | 9 | 576 | 3,199 | $281,538 | $96,884 |
| 2020 | 9 | 622 | 3,165 | $259,716 | $89,304 |
Total Patients
2,136
Total Services
9,455
Medicare Billing
$316,978
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 336 | 512 | $188,416 | $46,644 | 24.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 23 | 25 | $9,150 | $2,324 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $7,664 | $1,758 | 22.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 30 | 62 | $6,138 | $1,600 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $2,860 | $664.18 | 23.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 29 | 35 | $1,050 | $323.68 | 30.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 18 | $738.00 | $203.04 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 302 | 412 | $140,492 | $36,877 | 26.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 18 | 1,800 | $54,000 | $30,583 | 56.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 23 | $11,063 | $3,059 | 27.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 34 | 36 | $12,276 | $2,839 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 24 | $5,808 | $1,470 | 25.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 21 | 41 | $3,813 | $1,023 | 26.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 18 | 18 | $4,338 | $809.50 | 18.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 19 | 31 | $1,178 | $362.55 | 30.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 23 | 27 | $810.00 | $250.64 | 30.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 320 | 463 | $153,253 | $41,705 | 27.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 26 | 2,460 | $73,800 | $39,614 | 53.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 58 | 58 | $24,882 | $7,457 | 30.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 51 | $11,883 | $2,672 | 22.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 16 | $7,424 | $2,372 | 31.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 17 | 17 | $3,978 | $1,107 | 27.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 19 | 32 | $2,880 | $886.17 | 30.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 37 | 54 | $1,998 | $605.28 | 30.3% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 35 | 48 | $1,440 | $466.08 | 32.4% |
About Dr. Mihaela Cosma, M.D
Dr. Mihaela Cosma, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215915103.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mihaela Cosma, M.D has received a total of $4,918 in payments from pharmaceutical and medical device companies, with $1,006 received in 2024. These payments were reported across 172 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,769).
As a Medicare-enrolled provider, Cosma has provided services to 2,136 Medicare beneficiaries, totaling 9,455 services with total Medicare billing of $316,978. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Spokane, WA
- Active Since 01/03/2006
- Last Updated 04/30/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1215915103
Products in Payments
- Ozempic (Drug) $315.85
- EVENITY (Biological) $256.40
- MINIMED 780G (Device) $242.91
- INVOKANA (Drug) $230.72
- Korlym (Drug) $220.78
- Tresiba (Drug) $220.37
- Minimed 670G System (Device) $209.32
- JARDIANCE (Drug) $185.11
- STRENSIQ (Biological) $143.96
- AFREZZA (Drug) $136.25
- MOUNJARO (Drug) $129.03
- FREESTYLE LIBRE 2 (Device) $127.91
- Kerendia (Drug) $119.55
- Repatha (Biological) $110.81
- iLet Bionic Pancreas (Device) $104.60
- SOLIQUA (Drug) $88.14
- FORTEO (Drug) $84.82
- Yorvipath (Drug) $78.48
- Victoza (Drug) $78.14
- HUMULIN (Drug) $70.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Spokane
Carol Wysham, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $962,727
Endocrinology, Diabetes & Metabolism $962,727
Lynn Kohlmeier, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $493,965
Endocrinology, Diabetes & Metabolism $493,965
Harold Cathcart, Do, DO
Endocrinology, Diabetes & Metabolism — Payments: $89,976
Endocrinology, Diabetes & Metabolism $89,976
Dr. Jeffrey Hartman, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $3,830
Endocrinology, Diabetes & Metabolism $3,830
Lisanne Laurier, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $591.64
Endocrinology, Diabetes & Metabolism $591.64
Maria Janout, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $175.57
Endocrinology, Diabetes & Metabolism $175.57